Abstract
The effect of a diphosphonate, EHDP, was studied in two experimental models in the rat: local immobilization osteoporosis and systemic cortisone-induced osteoporosis. EHDP was able to prevent the local bone loss brought about by surgical immobilization of the left hind limb, but was ineffective in preventing the systemic bone loss produced by cortisone administration. The most prevalent action of EHDP is the production of large amounts of osteoid; it seems to have little effect on bone resorption. The lack of consistent findings in both models suggests that systemic bone-losing disorders cannot be extrapolated from local bone atrophy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
